IMX-110 + anti-PD-1 Combination Produced Extended Median Survival in Genetic…
IMX-110 + anti-PD-1 produced 63-day median survival in a genetic (KPC) pancreatic cancer mouse model in which mice develop their own pancreatic cancer and have an intact immune…